VC-backed SetPoint Medical names chief medical officer
Santa Clarita, California-based SetPoint Medical, a developer of bioelectronic therapy for chronic inflammatory diseases, has appointed Dr. David Chernoff as chief medical officer. Chernoff has been a chief medical officer for a number of companies that include Crescendo Bioscience, Adamas Pharma, XDX, CardioDX, Tethys Biosciences and Aquinox Pharma. SetPoint's backers include Morgenthaler Ventures, New Enterprise Associates, Topspin Partners, Medtronic, GlaxoSmithKline’s Action Potential Venture Capital Limited and Boston Scientific.
15 June 2017•3 mins read
